Skip to main content
PMC home page
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1965;32(5):683–697.

Immunization against neonatal tetanus in New Guinea

Antitoxin response of pregnant women to adjuvant and plain toxoids*

R MacLennan, F D Schofield, Margaret Pittman, M Carolyn Hardegree, Michael F Barile
PMCID: PMC2555243  PMID: 5294183

Abstract

Immunization of pregnant women in New Guinea with three injections of plain toxoid had previously been shown to prevent neonatal tetanus. In the present study antitoxin levels induced by two oil-adjuvant toxoids (one injection), one AlPO4 toxoid (two injections) and one plain toxoid (three injections) were compared with those induced by the same plain toxoid as used in the earlier study. At term there was no significant difference in the levels for the five toxoids, but those for the plain toxoids later declined rapidly. AlPO4-toxoid titres were significantly higher than the titres for the plain toxoids at the end of a year, but lower than the oil-adjuvant titres, which were the highest and most persistent. However, unacceptable side-effects (induced by subsequent lots of oil-adjuvant toxoids) preclude their routine use at present.

The results indicate that a maternal antitoxin level at delivery of 0.01 unit/ml is protective. Aluminium-compound toxoid rapidly achieved titres that were better than this for at least a year, with minimal side-effects. Hence such toxoids are recommended for maternal immunization to prevent neonatal tetanus.

Full text

PDF
687

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. EDSALL G. Active and passive immunity of the infant. Ann N Y Acad Sci. 1956 Aug 10;66(1):32–43. doi: 10.1111/j.1749-6632.1956.tb40100.x. [DOI] [PubMed] [Google Scholar]
  2. MCCOMB J. A. THE PROPHYLACTIC DOSE OF HOMOLOGOUS TETANUS ANTITOXIN. N Engl J Med. 1964 Jan 23;270:175–178. doi: 10.1056/NEJM196401232700404. [DOI] [PubMed] [Google Scholar]
  3. NICOL L., GIRARD O., CORVAZIER R., CHEYROUX M., RECULARD P., SIZARET P. [Comparative study of the transmission of immunity from mothers to newborn]. Rev Immunol Ther Antimicrob. 1960 Jan-Mar;24:16–23. [PubMed] [Google Scholar]
  4. PETERS W. Studies on the epidemiology of malaria in New Guinea. Part I. Holoendemic malaria--the clinical picture. Trans R Soc Trop Med Hyg. 1960 May;54:242–249. doi: 10.1016/0035-9203(60)90068-7. [DOI] [PubMed] [Google Scholar]
  5. SCHOFIELD F. D., PARKINSON A. D., KELLY A. CHANGES IN HAEMOGLOBIN VALUES AND HEPATOSPLENOMEGALY PRODUCED BY CONTROL OF HOLOENDEMIC MALARIA. Br Med J. 1964 Mar 7;1(5383):587–591. doi: 10.1136/bmj.1.5383.587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. SCHOFIELD F. D., PARKINSON A. D. Social medicine in New Guinea: beliefs and practices affecting health among the Abelam and Wam peoples of the Sepik District. I. Med J Aust. 1963 Jan 5;1(1):1–8. [PubMed] [Google Scholar]
  7. WILNER B. I., EVERS M. A., TROUTMAN H. D., TRADER F. W., MCLEAN I. W. VACCINE POTENTIATION BY EMULSIFICATION WITH PURE HYDROCARBON COMPOUNDS. J Immunol. 1963 Aug;91:210–229. [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES